Syringe dead space (revision 61)

Syringe dead space is the volume of liquid that remains inside a syringe and its needle after the plunger has been fully depressed. It occupies the cavity of the needle hub, the lumen of the needle itself and any recess in the face of the plunger tip, and it is not delivered to the injection site.^[1]

The quantity matters for two distinct reasons that are frequently conflated. First, the retained liquid is discarded with the device, so each injection consumes the nominal dose plus the dead-space volume; over the life of a reconstituted vial this reduces the number of doses obtainable. Second, if the dead space is occupied by air rather than liquid at the moment the plunger position is read against the graduations, and that air is subsequently expelled, the volume actually delivered is smaller than the volume indicated. The first effect is a wastage problem and does not alter the delivered dose; the second is a dose error and can be large.^[2]

Magnitudes vary across almost two orders of magnitude between device types. A 1 mL insulin syringe with a permanently attached fine needle has a dead space of a few microlitres, because the plunger tip enters the needle hub and displaces almost all of it. A general-purpose syringe with a detachable needle on a Luer fitting retains of the order of 70–100 µL, most of it in the hub rather than in the needle.^[1][3]

Because doses of reconstituted peptides are frequently in the range 0.05–0.30 mL, dead space of 0.07 mL is not a marginal quantity in this context: it is comparable to the dose. The choice of device therefore has arithmetic consequences that a dose expressed in milligrams conceals.^[4]

A hypodermic syringe delivers liquid by advancing a plunger through a graduated barrel. The graduations relate to the position of the plunger tip, so the volume expelled is the barrel volume swept between the starting and finishing plunger positions. Any volume distal to the plunger tip at full depression is outside that swept volume and is retained.

Three cavities contribute:

• the hub, the conical or cylindrical space between the end of the barrel and the proximal end of the needle cannula, which in a Luer fitting is a substantial void;
• the needle lumen, the bore of the cannula itself;
• the plunger-tip recess, any concavity in the elastomeric or moulded tip that is not filled by the barrel end when fully advanced.

Terminology in the literature is inconsistent. Dead space, dead volume, residual volume and hold-up volume are all used for the same quantity, and residual volume is also used in a different sense for liquid left in the source container after withdrawal. The two are separate: the liquid left in a vial because the needle cannot reach it, or because the vial geometry traps it, is a container property and is discussed at underfilling and at vial. This article uses dead space for the syringe-and-needle quantity only.^[5]

The distinction between high dead-space and low dead-space devices entered the literature through injecting-drug-use epidemiology, where the retained volume determines how much blood a shared syringe can transfer. Low-dead-space designs achieve their reduction either by moulding the needle permanently into a plunger-penetrable hub, or by fitting a plastic insert into an otherwise standard Luer hub so that the plunger tip advances into it.^[3]

Published measurements are made gravimetrically: the assembled device is filled, fully discharged, and the retained mass determined by weighing, with density assumed. Values below are representative of those reported in the injection-equipment literature and vary between manufacturers of nominally equivalent devices.^[1][3]

The consistent finding is that the hub dominates. This is counter-intuitive, because the needle is the visibly narrow and visibly long component, but the arithmetic is unambiguous once the lumen volume is computed from tubing dimensions.^[6]

Volumes are computed as the product of cross-sectional area and length; outside diameters follow the metric equivalents of the Birmingham gauge series used in ISO 9626, and inside diameters are typical regular-wall values.^[6] A 27G half-inch needle therefore holds 0.44 µL, roughly one part in 160 of a 70 µL hub. Changing needle gauge or length has almost no effect on dead space; changing the hub design changes it by an order of magnitude.

Doubling cannula length from 12.7 mm to 25.4 mm doubles the lumen volume, taking a 25G needle from 0.67 to 1.34 µL. Against a hub of 60–70 µL this is immaterial. Needle length is selected on anatomical grounds — 4, 6 and 8 mm pen needles and 12.7 mm syringe needles are the common lengths for subcutaneous administration — and not on dead-space grounds.^[7]

The two consequences are separable and are treated separately here because the distinction is the most common error in secondary discussion of the topic.

Wastage. When a syringe is filled by drawing liquid through the needle, the hub and lumen fill first and remain full. Setting the plunger tip to a graduation then places the nominal volume in the barrel in addition to the dead-space volume already drawn. Full depression delivers the barrel volume — the dose is correct — and discards the dead-space volume with the device. The loss is to vial yield, not to the dose.

Dose error. If an air pocket equal to the dead space sits in the hub when the graduation is read, the barrel contains that much less liquid than the graduation indicates. Expelling the air before injection then leaves a shortfall equal to the air volume. The proportional error is the dead-space volume divided by the intended dose.

A worked case. A vial containing 5.0 mg of peptide is reconstituted with 2.00 mL of diluent, giving 2.50 mg·mL⁻¹. An intended dose of 0.50 mg corresponds to 0.20 mL.

• With a device of 0.070 mL dead space and an unexpelled hub air pocket of that size, the liquid delivered is 0.20 − 0.07 = 0.13 mL, containing 0.325 mg. The shortfall is 35% of the intended dose.
• With the same device correctly primed and free of air, 0.20 mL and 0.50 mg are delivered, and 0.070 mL — 0.175 mg — is discarded in the device.
• For a smaller intended dose of 0.05 mL, the same 0.070 mL dead space exceeds the dose entirely; no plunger position can deliver 0.05 mL if that volume of air must first be displaced from the hub.

The vial-yield arithmetic follows from the wastage figure. Each dose consumes 0.20 mL delivered plus 0.070 mL retained, or 0.270 mL. From 2.00 mL, seven full doses can be drawn (7 × 0.270 = 1.89 mL), with 0.11 mL remaining — insufficient for an eighth. The nominal ten doses have become seven, a 30% reduction. With a fixed-needle insulin syringe at 0.005 mL, each dose consumes 0.205 mL and nine full doses can be drawn, with 0.155 mL remaining.^[4]

Figures assume that the entire nominal fill is accessible, which overstates yield: liquid trapped by vial geometry is additional and is not counted here.

The mechanism by which the dose error arises is the presence of gas where liquid is assumed. Descriptions of injection technique in manufacturers' prescribing information and in nursing references accordingly treat expulsion of air before the dose is measured as a defined step, and treat the graduation as valid only for a gas-free barrel and hub.^[8]

Two configurations make the error more likely. A detachable needle attached after the barrel has been filled introduces a hub full of air that must then be displaced. Reconstitution performed with one needle and injection with another — a common arrangement, since a wider gauge is easier to use for withdrawal — reintroduces an air-filled hub at the point of exchange. Neither is inherently unsafe, but both place the burden of correctness on a step that is easy to omit and whose omission is not visible afterwards.^[2]

ISO 7886-1 specifies that a syringe deliver its graduated volume within a stated tolerance when used according to the manufacturer's instructions, which include expulsion of air. At nominal capacity the tolerance is ±5%; at low fractions of capacity the permitted deviation is larger in relative terms, because it is expressed against a fixed fraction of nominal volume rather than against the volume drawn. A 1 mL syringe used to deliver 0.10 mL is therefore operating in a region where the device standard itself concedes poor relative accuracy, independent of dead space.^[5][9]

This is a separate error source from dead space and the two are additive. Insulin syringes carry the tighter requirements of ISO 8537 and are graduated in units rather than in millilitres, which introduces the conversion problem discussed at Insulin syringe unit conversion.^[9]

Interest in reducing dead space arose in two unrelated fields.

In injecting-drug-use epidemiology, the retained volume determines how much blood a syringe carries between users. Modelling work has argued that widespread substitution of low-dead-space devices would materially reduce transmission of blood-borne viruses, on the basis that the residual blood volume — and therefore the inoculum — is reduced by more than an order of magnitude. The argument is a modelling argument supported by laboratory measurement of retained blood volume rather than by a trial of transmission outcomes, and it has been presented as such.^[1][3][10]

In vaccination and pandemic preparedness, dead space determines how many doses can be drawn from a fixed vial, and therefore how far a constrained supply extends. Analyses during influenza-preparedness planning noted that substituting devices of a few microlitres of dead space for devices of 70–80 µL could increase the number of doses obtainable from a multi-dose presentation by a substantial fraction, and that the effect is proportionally larger the smaller the dose.^[2][8]

Design approaches fall into three groups:

• Permanently attached needle. The cannula is moulded into the barrel and the plunger tip advances to its proximal end. This achieves the lowest values, of the order of 2–6 µL, and is the standard construction for insulin syringes.
• Hub insert. A moulded plastic plug fills most of a standard Luer hub, leaving a channel for liquid, so that a conventional detachable-needle syringe achieves roughly 10 µL. The needle remains detachable, which preserves the operational flexibility of a Luer fitting.
• Extended plunger tip. The plunger tip carries a projection that enters the hub. Values are intermediate and depend on the fit achieved.

Trade-offs are documented. Permanently attached needles cannot be exchanged between withdrawal and injection, which is inconvenient when a wide-bore needle is wanted for withdrawal from a stoppered vial and a fine one for injection. Fine permanently attached needles are also slower to draw viscous liquids and are more easily bent or blunted by passage through an elastomeric closure, a route by which stopper coring becomes more likely.^[8]

Dead space is not itself a specified parameter in the principal device standards. ISO 7886-1 specifies the graduated capacity, the tolerance on delivered volume, dimensional requirements, freedom from leakage and the force required to operate the plunger; ISO 8537 does the equivalent for insulin syringes; ISO 7864 covers needles and ISO 9626 the stainless-steel tubing from which they are made. None sets a maximum retained volume, and none requires it to be declared.^[5][9][7][6]

The practical consequence is that dead space must be measured or inferred rather than looked up. Published measurement follows a gravimetric protocol: the device is assembled, filled with water of known temperature, fully discharged against no back-pressure, and weighed before and after; the retained mass converted to volume gives the dead space. Reported precision is adequate to distinguish the device classes in the table above but not to distinguish nominally identical products from different manufacturers, where differences of 10–20 µL have been reported.^[1]

Because the parameter is undeclared, comparison between published studies requires care. Studies differ in whether the needle is included, whether the measurement is made with the plunger merely bottomed or forced, and whether back-pressure representative of tissue is applied. Values quoted without those details are not strictly comparable, and a difference between two published figures for the same device class is at least as likely to reflect protocol as product.^[10]

Community-collated measurements of devices commonly used with reconstituted research peptides exist but are self-reported, use domestic balances of unstated calibration status, and do not control for the protocol variables above. They are consistent with the published device classes in magnitude and are not adequate to support finer distinctions.^[4]

Three recurring problems make the topic harder to read about than its physics warrants.

The first is the conflation described above: a dead-space volume is quoted as though it were automatically a dose error. It is only a dose error under a specific condition — gas occupying the dead space when the dose is measured — and the condition is often left implicit.

The second is the use of dead space as a device-quality claim. A device may be marketed on a low retained volume without stating how the figure was obtained, and because no standard requires the declaration, no comparability can be assumed. Marketing figures and gravimetrically measured figures for the same product have differed.^[3]

The third is the omission of dead space from dose arithmetic altogether. Reconstitution guidance and calculators commonly convert a target mass to a volume using the concentration, and stop there. That conversion is correct for the delivered dose but silent on how many doses a vial will actually yield, which is the figure a reader is often trying to obtain. The article Reconstitution calculator treats the arithmetic; the omission is noted here because it is systematic rather than occasional.^[4]

None of these problems is difficult to correct in prose, and all three appear in otherwise careful sources.

• Insulin syringe
• Subcutaneous injection
• Reconstitution of lyophilised peptides
• Insulin syringe unit conversion
• Reconstitution calculator
• Multi-dose vial
• Sharps disposal

• World Health Organization and UNAIDS. Technical Brief: Low Dead Space Syringes — the public-health framing of the parameter.
• Frid AH, Kreugel G, Grassi G, et al. "New insulin delivery recommendations." Mayo Clinic Proceedings 91(9):1231–1255 (2016) — needle length and technique, with dead space treated in passing.

• ISO 7886 series (catalogue entry) — Device standards for single-use hypodermic syringes. Paywalled.